ClinicalTrials.gg
Not yet recruitingNCT07776093Updated Aug 24, 2026

Manual Therapy vs. Multicomponent Exercise in Cervicogenic Headache

An interventional study of Manual Therapy Protocol and Multicomponent Exercise Program in Cervicogenic Headache, Proprioceptive Disorders and Neck Pain Musculoskeletal, sponsored by Pamukkale University. Not yet recruiting. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The purpose of this study is to compare the effects of manual therapy and a multicomponent exercise program on suboccipital muscle thickness, joint position sense, pain, central sensitization, balance, and kinesiophobia in patients diagnosed with cervicogenic headache.

Cervicogenic headache is a common secondary headache originating from dysfunction in the upper cervical spine. Dysfunction in the deep neck muscles, impaired neck joint awareness, and heightened pain sensitivity (central sensitization) are frequently observed in these patients. While both manual therapy and targeted exercise are used in physiotherapy practice, evidence regarding their direct comparative effects on suboccipital muscle morphology and somatosensory parameters remains limited.

Participants will be randomly assigned to one of two treatment groups for a duration of 4 weeks (12 sessions total):

  1. Manual Therapy Group: Receives joint mobilization, myofascial release, trigger point release, and suboccipital distraction targeting the cervical region.
  2. Multicomponent Exercise Group: Receives deep cervical flexor strengthening, cervical proprioception training, head-eye coordination training, and progressive balance exercises.

The main questions the study aims to answer are:

  • Do manual therapy and multicomponent exercise improve suboccipital muscle thickness and cervical joint position sense in patients with cervicogenic headache?
  • Is there a significant difference between manual therapy and multicomponent exercise in reducing pain intensity, central sensitization, disability, and fear of movement (kinesiophobia)? It is hypothesized that both intervention protocols will yield significant clinical improvements, with specific synergistic adaptations in muscle structure, somatosensory system processing, and pain-related fear.
02

Conditions studied

  • Cervicogenic Headache
  • Proprioceptive Disorders
  • Neck Pain Musculoskeletal
03

In context

Post-Traumatic Headache

192 studies on the registry are indexed under Post-Traumatic Headache; 54 are open to participants now.

This study's planned enrollment of 32 is below the median of 44 across 169 interventional studies indexed under Post-Traumatic Headache.

Browse Post-Traumatic Headache studies →

Lead sponsor

Pamukkale University is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of cervicogenic headache by a specialist physician,
  • Aged between 18 and 45 years,
  • Ability to read and write (literate),
  • Provision of signed to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • History of head or neck surgery,
  • History of spinal surgery,
  • History of severe cardiac conditions or cardiac surgery that contraindicates exercise,
  • History of ongoing or past ,
  • Diagnosis of psychiatric disorders,
  • Diagnosis of migraine,
  • Diagnosis of fibromyalgia,
  • Having received medical (except analgesics), physical therapy, or other interventions (e.g., alternative medicine, massage therapy) for cervicogenic headache within the last 6 months,
  • Engaging in regular exercise or attending an exercise facility within the last 6 months,
  • Experiencing headaches strictly associated with the menstrual period,
  • Investigator decision for exclusion based on ethical or clinical grounds,
  • Communication problems interfering with evaluation and treatment.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Manual Therapy Group

    Participants in this arm will receive 12 sessions of manual therapy (3 sessions per week for 4 weeks). Interventions include upper cervical joint mobilization, myofascial release, suboccipital distraction, and trigger point therapy targeting the suboccipital and cervical region.

    Procedure: Manual Therapy Protocol

  • Active comparator
    Multicomponent Exercise Group

    Participants in this arm will receive 12 sessions of a multicomponent exercise program (3 sessions per week for 4 weeks). Interventions include deep cervical flexor strengthening, cervical proprioception training, gaze stability/head-eye coordination exercises, and progressive postural balance training.

    Other: Multicomponent Exercise Program

Interventions

  • ProcedureManual Therapy Protocol

    Upper cervical joint mobilization, myofascial release, suboccipital distraction, and trigger point therapy targeting the cervical region.

  • OtherMulticomponent Exercise Program

    Deep cervical flexor strengthening, cervical proprioception exercises, gaze stability/head-eye coordination training, and progressive balance exercises.

06

What researchers measure

Primary outcomes

  1. Change from Baseline Pain Intensity

    Evaluated using a 10-cm Visual Analog Scale (VAS) measured in centimeters to assess headache pain intensity.

    Time frame: Baseline and Post-intervention (Week 4)

  2. Change from Baseline Central Sensitization Inventory Score

    Assessed using the 25-item Central Sensitization Inventory (CSI) with a total score ranging from 0 to 100 to evaluate the severity of central sensitization.

    Time frame: Baseline and Post-intervention at 4 Weeks

  3. Change from Baseline Tampa Scale for Kinesiophobia Score

    Evaluated using the Tampa Scale for Kinesiophobia (TSK) 4-point Likert scale (17-68 score range) to measure fear of movement and re-injury.

    Time frame: Baseline and Post-intervention at Week 4

  4. Change from Baseline Migraine Disability Assessment Score

    Assessed using the 5-item Migraine Disability Assessment (MIDAS) questionnaire to evaluate the total number of days with headache-related disability (score range 0 to 21+ for disability severity grades I to IV)

    Time frame: Baseline and Post-intervention at 4 Weeks.

  5. Change from Baseline Neck Disability Index Score

    Evaluated using the 10-item Neck Disability Index (NDI) questionnaire to measure neck pain-related functional disability (score range 0 to 50, higher scores indicating higher disability).

    Time frame: Baseline and Post-intervention at 4 Weeks

Secondary outcomes

  1. Change from Baseline Suboccipital Muscle Thickness

    Evaluated using B-mode ultrasonography (9-12 MHz linear probe) to measure the thickness (in millimeters) of the rectus capitis posterior major (RCPM) and obliquus capitis superior (OCS) muscles bilaterally at the C1-C2 level.

    Time frame: Baseline and Post-intervention at 4 Weeks

  2. Change from Baseline Cervical Joint Position Sense Error

    Evaluated using the Cervical Range of Motion (CROM) device to measure cervical joint position error (in degrees) at target angles set at 65% of the participant's active range of motion.

    Time frame: Baseline and Post-intervention at 4 Weeks

  3. Change from Baseline Head-Eye Movement Control Test Score

    Evaluated using the Head-Eye Movements Control Test, scored as 0 (negative/stable), 1 (moderately positive), or 2 (strongly positive/unstable).

    Time frame: Baseline and Post-intervention at Week 4

  4. Change from Baseline Deep Cervical Flexor Muscle Endurance

    Assessed in seconds using the Cervical Deep Neck Flexor Muscle Endurance Test in a hook-lying chin tuck position.

    Time frame: Baseline and Post-intervention (Week 4).

  5. Change from Baseline Postural Balance Score

    Measured using the Sway mobile application across five stance positions (feet together, left/right tandem, left/right single-leg) under blindfolded conditions, producing a total balance score from 0 to 100.

    Time frame: Baseline and Post-intervention at Week 4

  6. Change from Baseline Cervical Range of Motion

    Evaluated using the Baseline CROM Deluxe device to measure active cervical flexion, extension, right/left lateral flexion, and right/left rotation in degrees. Two trials will be performed for each movement and the arithmetic mean will be analyzed.

    Time frame: Baseline and Post-intervention at 4 Weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07776093
Responsible party
Borna Farhoomand (Physiotherapist, Pamukkale University) — Principal investigator
First posted
Aug 20, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Aug 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion